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ABSTRACT
We have developed a web tool, PupasView, for the
selection of single nucleotide polymorphisms (SNPs)
with potential phenotypic effect. PupasView consti-
tutes an interactive environment in which functional
information and population frequency data can be
used as sequential filters over linkage disequilibrium
parameters to obtain a final list of SNPs optimal for
genotyping purposes. PupasView is the first resource
that integrates phenotypic effects caused by SNPs at
both the translational and the transcriptional level.
PupasViewretrievesSNPsthatcouldaffectconserved
regionsthatthecellularmachineryusesforthecorrect
processingofgenes(intron/exonboundariesorexonic
splicing enhancers), predicted transcription factor
binding sites and changes in amino acids in the
proteins for which a putative pathological effect is
calculated. The program uses the mapping of SNPs
in the genome provided by Ensembl. PupasView will
be of much help in studies of multifactorial disorders,
wheretheuseoffunctionalSNPswillincreasethesens-
itivity of the identification of the genes responsible for
thedisease.ThePupasViewwebinterfaceisaccessible
through http://pupasview.ochoa.fib.es and through
http://www.pupasnp.org.
INTRODUCTION
Single nucleotide polymorphisms (SNPs) are the simplest
and most frequent type of DNA sequence variation among
individuals and, with the recent availability of high-
throughput methodologies, are considered one of the most
powerful tools in the search for e.g. disease susceptibility
genes and drug response-determining genes (1,2). However,
complex diseases, for which markers display weak associ-
ations, still constitute a challenge. Most probably, advance-
ment in the knowledge of such diseases will come from
improved genotyping methods in combination with the proper
bioinformatics design strategies (3).
It is generally believed that multigenicity reﬂects disrup-
tions in proteins that participate in a protein complex or in a
pathway (4). Typically, SNPs have been used as markers; that
is, the real determinant of the disease was not the SNP itself
but some other mutation in linkage disequilibrium (LD) with
it. Because of this, the use of functional SNPs could be an
important factor in increasing signiﬁcantly the sensitivity of
association tests. In fact, several complex genetic disorders
such as Alzheimer’s disease (5) and Crohn’ disease (6) have
been associated with functional SNPs, lending weight to strat-
egies giving priority to candidate markers based upon predict-
able function. Several estimations suggest that, on average,
some 20% of SNPs could directly damage proteins (7).
Much attention has been focused on modelling by different
methods the possible phenotypic effect of SNPs that cause
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doi:10.1093/nar/gki476amino acid changes (7–13), and only recently has interest
focused on functional SNPs affecting regulatory regions or
the splicing process (14). However, there is increasing evid-
ence that many human disease genes are the result of exonic or
non-coding mutations affecting regulatory regions (15–17).
A recent large-scale screening over a set of 16 chromosomes
found SNPs in the promoter regions of 35% of the genes, and
experimental evidence suggested that around a third of
promoter variants may alter gene expression to a functionally
relevant extent (18). Alternative splicing produced by muta-
tions in intron/exon junctions, or in distinct binding motifs,
such as exonic splicing enhancers (ESEs) (19), has also been
related to different diseases (20). In fact, it has been estimated
that 15% of point mutations that result in human genetic
diseases cause RNA splicing defects (21).
In addition to functional information, population frequency
is another important factor to be taken into account when
selecting SNPs. Thus, infrequent polymorphisms will be of
scarce interest as markers. Also, LD is another interesting
factor in selecting SNPs as markers since, if two SNPs are in
strong LD, only one of them will provide enough information
for any association or linkage test.
With the idea of selecting optimal sets of SNPs using as
much information as possible on putative phenotypic effect,
population frequencies and LD, we have developed Pupas-
View (Putative Phenotypic Alterations caused by SNPs
Viewer), a server that can be used alone or in combination
with PupaSNP (14).
PupasView works not only as a viewer of where SNPs are
located, butalsoasaselectorinwhich different ﬁlters based on
combinations of functionality and population frequencies can
be interactively applied over the LD parameters in order to
obtain an optimal selection of SNPs for genotyping studies, in
such a way that with a minimum number of SNPs maximum
information on the genic region is obtained.
Criteria to consider an SNP a good candidate for
genotyping studies
There are three important properties for an SNP to be con-
sidered an optimal candidate for genotyping purposes: func-
tional effect, minor allele frequency and LD with respect to
other SNPs. Finding such optimal SNPs is not always possible,
but the idea behind PupasView is to facilitate the selection
process in order to achieve a ﬁnal collection of SNPs bearing
the maximum amount of information. PupasView works as an
SNP selector. Different ﬁlters can be interactively applied to
the LD information available based on distinct functional
properties, cross-species conservation and population fre-
quency. This permits a ﬁnal selection of a minimum number
of SNPs with optimal properties in terms of population
frequencies and potential phenotypic effect.
Finding SNPs with potential phenotypic effect
PupasView uses a precompiled database which contains a
collection of dbSNP entries mapped to the Golden Path
genome assembly, as implemented in the human section of
Ensembl (http://www.ensembl.org). Part of this database is
common to the PupaSNP program (14). The SNPs have
been labelled according to their potential effects on the pheno-
type.We have taken into accountboth transcriptional and gene
product levels. Regions 10 000 bp upstream of the genes
belonging to the promoter region of each gene in the list
have been scanned for the presence of possible different
regulatory motifs. These include alterations in:
(i) Transcription factor binding sites. Promoter regions were
scanned for the presence of possible transcription factor
binding sites. The program Match (22) was used for
this purpose, using only high-quality matrices and with
a cut-off to minimize false positives from the Transfac
database (23). SNPs located within these motifs are con-
sidered to have a putative phenotypic effect in the expres-
sion of the gene. Almost four million such motifs were
found, with 130 373 SNPs mapping onto them.
(ii) Intron/exon border consensus sequences. Ensembl APIs
(24) were used to extract the intron/exon organization of
the genes and the corresponding sequences. The two con-
servednucleotidesoneachsideofthesplicingpoint,which
constitutethesplicingsignal(21),werethenlocatedandall
the SNPs altering these signals were recorded. More than
700000intron/exonboundariescouldbedefinedinhuman
genes with 1786 SNPs mapping onto them.
(iii) ESEs. Mutations that inactivate or activate an ESE
sequencemayresultinexonskipping,errors inalternative
splicing patterns, malformation and so on. Different
classes of ESE consensus motifs have been described,
but they are not always easily identified. Exon sequences
were scanned to identify putative ESEs responsive to the
human SR proteins SF2/ASF, SC35, SRp40 and SRp55,
using the available weight matrices (20). A score was
obtained that is related to the likelihood that the site
found is a real ESE. Only ESE sites with scores over the
threshold [see (20) for details] were taken into account in
the analysis. More than 11 million ESEs were found, with
299 106 SNPs located in them.
(iv) Triplex-formingoligonucleotidetarget sequences(TTSs).
IthasbeenfoundthatthepopulationofTTSsismuchmore
numerousthanexpectedfromsimplerandommodels(25).
The population of TTSs is large in the whole genome,
without major differences between chromosomes, but
withalargeconcentrationinregulatoryregions,especially
in promoter zones, which suggests a tremendous potential
for triplex strategy in the control of gene expression (25).
Although the role of TTSs in regulation is still a matter of
speculation, the program also reports SNPs disrupting
these structures. Some 5.4 million putative triplex-
formingsequenceswerefound,and364314SNPsmapped
onto them.
(v) SNPs in exons that cause an amino acid change.AnySNP
causing a change of amino acid, independent of any
speculation on its possible phenotypic effect, is reported.
There are 45 906 such SNPs.
(vi) SNPs in exons that cause an amino acid change with
putative pathological effect. The putative pathological
effect of an amino acid change can be predicted using
neuralnetworks(NNs)carefullytrainedtopredictdisease-
associatedaminoacidicpolymorphism(12,13).Theserver
implements a small NN (1 hidden layer and 20 nodes) and
three sequence-derived descriptors (PAM40, PSSM and
variability), which are either retrieved from databases or
determined internally from multiple alignments using
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SwissProt/TrEMBL database. The trained method dis-
playsasuccessrate>80%incross-validationexperiments.
According to the algorithm, 19 309 SNPs displayed a high
probability of having pathological effect.
(vii) Human–mouse conserved regions. Untranslated whole
genome comparisons by BLASTZ were performed for
species pairs which are thought to be similar enough to
be able to detect homology directly at the DNA level (27).
Of particular interest is mouse (or rat) because of its
phylogenetic position with respect to humans: distant
enough to interpret conservation as important but not so
distant as to lose most of the similarity. The phenotypic
effect of a change in such regions is quite speculative, but
cross-species conservation can be useful in cases in which
no other information is available. It is also useful for rein-
forcingthelikelihoodofotherpredictions(e.g.anESEina
conserved region is more likely to be real than one in a
non-conserved region).
Frequency information and validation status
There are >10 million SNPs stored in the last build of dbSNP
(build 124), and more than half of these have been validated
by different means (http://www.ncbi.nlm.nih.gov/SNP/snp_
summary.cgi). Validation status is annotated and is an import-
ant ﬁeld in terms of trusting an SNP. But, in addition to being
real, an SNP must exist in the population at frequencies which
make it a suitable marker. Very infrequent SNPs are not
suitable for association or linkage studies. For almost half a
million SNPs frequency data in different populations are
available.
Blocks and LD parameters
LD measures the correlation between two neighbouring gen-
etic variants in a speciﬁc population. The program HaploView
(28) is used to infer blocks using different procedures. In one
of the most common procedures (29), 95% conﬁdence bounds
based on the D0 LD parameter are generated and each com-
parison is called ‘strong LD’, ‘inconclusive’ or ‘strong
recombination’. A block is created if 95% of informative
(i.e. non-inconclusive) comparisons are ‘strong LD’. A block
can be considered a region with a low recombination rate.
Ideally, a block could properly be described by a unique
SNP. Two other methods are used: the four gamete rule
(30) and the Solid Spine of LD (28). Blocks are displayed
in the bottom of the PupasView window. Also D0, R
2 and LOD
parameters between adjacent SNPs can be visualized by pla-
cing the cursor between them. Only HapMap genotyped
SNPs (31) are used to calculate blocks and LD parameters.
The web interface of the SNPs selector
The main purpose of PupasView is to provide the user with an
optimal set of SNPs for genotyping experiments by ﬁltering
the annotated SNPs using a series of ﬁlters related to their
impact in protein functionality and pathology, their population
frequency and LD.
The input is a gene identiﬁer (Ensembl IDs or external IDs,
which include GenBank, Swissprot/TrEMBL and other gene
IDs supported by Ensembl). The program can also be invoked
from PupaSNP. The program presents a list of options that can
be selected and applied as many times as desired. The options
include
  Validation status obtained from dbSNP
  Type of SNP (coding, intron, untranslated region, local),
according to its position in the gene
  Frequency and population, an option that allows the possi-
bilityoffilteringbyarangeoffrequenciesoftheminorallele
in one or more populations (Europe; Europe, multinational;
Europe, North America; North America; Central/South
America; North/East Africa and Middle East; Central/
South Africa; West Africa; Central Asia; East Asia; Pacific;
multinational; unknown; HapMap)
  Functional properties as follows:
– non-synonymous SNPs [all or only those predicted as
pathological by the pmut algorithm (12,13)]
– SNPs disrupting predicted transcription factor binding
sites (all or only those that are in regions conserved in
the mouse genome)
– SNPs disrupting predicted ESEs (all or only those that
are in regions conserved in the mouse genome)
– SNPs disrupting potential triplex-forming regions (all or
only those that are in regions conserved in the mouse
genome)
– SNPs disrupting intron/exon boundaries
– regions conserved in mouse
  Options for the way in which blocks are constructed:
– conﬁdence intervals (29)
– four gamete rule (30)
– Solid Spine of LD (28).
Figure 1 shows the view of the results. The viewer of
PupasView has been constructed using Ensembl APIs (24).
Figure 1A shows the result of running PupasView on the gene
TP53 without applying any ﬁlter. All the SNPs in the gene and
the neighbourhood are displayed. If the cursor is over an SNP,
information on it is displayed by means of pop-up text.
Figure 1B shows a subselection of these SNPs obtained
after selecting only SNPs for which population frequency
was available. Finally, Figure 1C shows the selection obtained
if only SNPs with putative functional effect are chosen. This
will constitute the ﬁnal, reduced subset of optimal SNPs. The
upper horizontal bar below the ﬁgure represents LD paramet-
ers (which can be individually obtained by placing the cursor
over them). The lower horizontal bar represents the block
found with the selected algorithm. The blocks are displayed
graphically with brown rectangles going from the ﬁrst to the
last SNP within the block. When the cursor is over the rect-
angles, a tooltip text pops up in the block showing the SNPs
and the haplotypes (with HapMap frequencies in parentheses).
Tag SNPs are signalled with an exclamation mark (!).
DISCUSSION
It is believed that improved genotyping methods in combina-
tion with the proper bioinformatics design strategies will offer
better opportunities for the study of complex diseases (3). The
use of functional SNPs could be an important factor in increas-
ingthe sensitivity ofassociationtests.Differentbioinformatics
approaches have been focused mainly on the effect of coding
SNPs, but also recently on SNPs affecting the regulation or the
splicing of genes (14).
Nucleic Acids Research, 2005, Vol. 33, Web Server issue W503PupasView is the ﬁrst tool that integrates both transcrip-
tional and translational phenotypic effects caused by poly-
morphisms. It provides an interactive environment in which
functional information and population frequency data can be
used over LD parameters as sequential ﬁlters to obtain a ﬁnal
list of SNPs optimal for genotyping purposes.
PupasView is closely linked to our previous program
PupaSNP (14),which is a tool for selecting SNPs with putative
phenotypic effects. PupaSNP, designed for high-throughput
experiments, has been used to design >9000 sets of SNPs,
andhasadailyaverageof50uses.PupasViewassistsinthelast
reﬁnement step of gene-by-gene selection of SNPs. Figure 1
illustrates the effect of applying successive ﬁlter steps, which
are, conceptually, ﬁrst to select only those SNPs which are real
(with reported population frequencies) and then to select only
functional SNPs. In the last view (Figure 1C), LD parameters
can be used to help in the ﬁnal selection.
More than 5000 SNPs have been selected using PupaSNP
and PupasView in the ﬁrst step of the pipeline for the study of
polymorphisms at the Spanish National Genotyping Centre
(CeGen).
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